You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 89 No. 2, FEBRUARY 1952 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

TERRAMYCIN THERAPY OF URINARY TRACT INFECTIONS

C. RAY WOMACK, M.D.; GEORGE GEE JACKSON, M.D.; THOMAS M. GOCKE, M.D.; EDWARD H. KASS, Ph.D., M.D.; THOMAS H. HAIGHT, M.D.; MAXWELL FINLAND, M.D.

AMA Arch Intern Med. 1952;89(2):240-257.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

AS PART of a general clinical evaluation of terramycin in the tratment of infections,1 a detailed study was undertaken to determine the usefulness of this agent in therapy of infections of the urinary tract. While it is generally stated that treatment with the so-called broad-spectrum antibiotics is highly effective in urinary infections, there are few reports of their use in large numbers of carefully studied cases. The present report deals with the clinical and bacteriologic findings for more than 100 patients who were treated with terramycin for acute or chronic infections of the urinary tract.

MATERIALS AND METHODS

Patients.

—A total of 107 patients was studied, including 2 who were treated during two separate admissions and 1 during four admissions for recurrent episodes. All the patients had bacteria and pus cells demonstrated in the urine before terramycin administration was started, but five patients with symptoms referable to urinary tract . . . [Full Text PDF of this Article]


Author Affiliations

BOSTON

From the Thorndike Memorial Laboratory, Second and Fourth Medical Services (Harvard), Boston City Hospital, and the Department of Medicine, Harvard Medical School.


Footnotes

This study was aided by grants from the United States Public Health Service and from the Milton Fund.

Dr. Womack is Post-Doctorate Research Fellow, National Institutes of Health; Dr. Jackson is Milton Fellow, Harvard Medical School, and Dr. Kass is Senior Fellow in Virus Diseases, National Research Council.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1952 American Medical Association. All Rights Reserved.